Form S-1 Decoy Therapeutics Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/27/2026
- Wall St climbs after US, Iran pause conflict; focus on Fed, earnings
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?
- Oil prices near one-week low after US, Iran pause fighting over weekend
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- Taiwan Semi (TSM) PT Raised to $530 at Needham
- Strategy sells MSTR shares, doesn't buy bitcoin
Decoy Therapeutics (DCOY) files for 3.77M share offering by selling stockholders
July 10, 2026 4:28 PM EDTDecoy Therapeutics (NASDAQ: DCOY) has filed for up to 3,766,500 share offering by selling stockholders.
... More
